Daniel Bergman
Daniel Bergman
Verifierad e-postadress på slu.se - Startsida
Titel
Citeras av
Citeras av
År
Insulin-like growth factor 2 in development and disease: A mini-review
D Bergman, M Halje, M Nordin, W Engström
Gerontology 59 (3), 240-249, 2012
1532012
Epigenetic regulation of the Igf2/H19 gene cluster
M Nordin, D Bergman, M Halje, W Engström, A Ward
Cell proliferation 47 (3), 189-199, 2014
972014
The effect of insulin-like growth factor II in the regulation of tumour cell growth in vitro and tumourigenesis in vivo
M Halje, M Nordin, D Bergman, W Engström
In Vivo 26 (4), 519-526, 2012
172012
Prevalence of interfering antibodies in dogs and cats evaluated using a species‐independent assay
D Bergman, A Larsson, H Hansson‐Hamlin, A Svensson, BS Holst
Veterinary Clinical Pathology 47 (2), 205-212, 2018
32018
Characterization of canine anti-mouse antibodies highlights that multiple strategies are needed to combat immunoassay interference
D Bergman, A Larsson, H Hansson-Hamlin, E Åhlén, BS Holst
Scientific Reports 9 (1), 1-9, 2019
22019
Investigation of interference from canine anti‐mouse antibodies in hormone immunoassays
D Bergman, A Larsson, H Hansson‐Hamlin, B Ström Holst
Veterinary Clinical Pathology 48 (Suppl. 1), 59-69, 2019
22019
Pre-existing canine anti-IgG antibodies: implications for immunotherapy, immunogenicity testing and immunoassay analysis
D Bergman, C Bäckström, H Hansson-Hamlin, A Larsson, BS Holst
Scientific Reports 10 (1), 1-10, 2020
2020
Canine heterophilic antibodies
D Bergman
Acta Universitatis Agriculturæ Sueciæ 2020 (2020: 22), 2020
2020
Grb10 and developmental programming: evaluation of a maternal diet restriction model during gestation
D Bergman
SLU, Dept. of Biomedical Sciences and Veterinary Public Health 2015 (61), 2015
2015
Systemet kan inte utföra åtgärden just nu. Försök igen senare.
Artiklar 1–9